hesperidin has been researched along with Atherogenesis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JY; Shim, SH | 1 |
| Caimari, A; Crescenti, A; Del Bas, JM; Domenech-Coca, C; Escoté, X; Mas-Capdevila, A; Teichenne, J | 1 |
| Chen, X; Wu, H; Xu, D; Zou, D | 1 |
| Chen, JF; Shen, LM; Sun, YZ; Wang, CF; Zhou, J | 1 |
| Assini, JM; Huff, MW; Mulvihill, EE | 1 |
| Bennetau-Pelissero, C; Bérard, AM; Chanet, A; Claude, S; Kamran Khan, M; Maier, JA; Mazur, A; Milenkovic, D; Morand, C; Rakotomanomana, N; Shinkaruk, S | 1 |
| MOSES, C | 1 |
2 review(s) available for hesperidin and Atherogenesis
| Article | Year |
|---|---|
Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Biological Availability; Cardiovascular Diseases; Cardiovascular System; Citrus; Dysbiosis; Dyslipidemias; Flavanones; Gastrointestinal Microbiome; Hesperidin; Humans; Obesity; Risk Factors | 2020 |
Citrus flavonoids and lipid metabolism.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Citrus; Dyslipidemias; Flavanones; Flavones; Hesperidin; Humans; Hypolipidemic Agents; Inflammation; Lipid Metabolism; Oxidation-Reduction; Phytotherapy | 2013 |
5 other study(ies) available for hesperidin and Atherogenesis
| Article | Year |
|---|---|
Anti-Atherosclerotic Effects of Fruits of
Topics: Apigenin; Apolipoprotein A-I; Atherosclerosis; Chromatography, High Pressure Liquid; Flavonoids; Fruit; Hesperidin; Humans; Lipid Peroxidation; Lipoproteins, HDL; Lipoproteins, LDL; Luteolin; Plant Extracts; Protein Aggregates; Vanillic Acid; Vitex | 2019 |
Hesperetin inhibits foam cell formation and promotes cholesterol efflux in THP-1-derived macrophages by activating LXRα signal in an AMPK-dependent manner.
Topics: AMP-Activated Protein Kinase Kinases; Atherosclerosis; Cholesterol; Foam Cells; Hesperidin; Humans; Liver X Receptors; Protein Kinases; THP-1 Cells | 2021 |
Anti-atherosclerotic effect of hesperidin in LDLr
Topics: Animals; Atherosclerosis; Diet, High-Fat; Foam Cells; Hesperidin; Male; Mice; Oxidative Stress; Receptors, LDL | 2017 |
Flavanone metabolites decrease monocyte adhesion to TNF-α-activated endothelial cells by modulating expression of atherosclerosis-related genes.
Topics: Atherosclerosis; Cell Adhesion; Endothelial Cells; Flavanones; Gene Expression Profiling; Gene Expression Regulation; Glucuronides; Hesperidin; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Monocytes; Sulfates; Tumor Necrosis Factor-alpha | 2013 |
The effect of phosphorylated hesperidin on experimental atherosclerosis.
Topics: Arteriosclerosis; Atherosclerosis; Flavones; Hesperidin; Humans; Hyaluronoglucosaminidase; Phosphorylation | 1954 |